An overview of joint modeling of time-to-event and longitudinal outcomes G Papageorgiou, K Mauff, A Tomer, D Rizopoulos Annual review of statistics and its application 6 (1), 223-240, 2019 | 156 | 2019 |
Personalized schedules for surveillance of low-risk prostate cancer patients A Tomer, D Nieboer, MJ Roobol, EW Steyerberg, D Rizopoulos Biometrics 75 (1), 153-162, 2019 | 26 | 2019 |
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance A Tomer, D Nieboer, MJ Roobol, A Bjartell, EW Steyerberg, D Rizopoulos, ... BJU international 127 (1), 96-107, 2021 | 16 | 2021 |
Personalized decision making for biopsies in prostate cancer active surveillance programs A Tomer, D Rizopoulos, D Nieboer, FJ Drost, MJ Roobol, EW Steyerberg Medical Decision Making 39 (5), 499-508, 2019 | 14 | 2019 |
Active surveillance: a review of risk-based, dynamic monitoring D Nieboer, A Tomer, D Rizopoulos, MJ Roobol, EW Steyerberg Translational andrology and urology 7 (1), 106, 2018 | 13 | 2018 |
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit A Tomer, D Nieboer, MJ Roobol, EW Steyerberg, D Rizopoulos Statistics in Medicine 41 (12), 2115-2131, 2022 | 8 | 2022 |
Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium. Personalised biopsy schedules based on risk of Gleason upgrading for patients … A Tomer, D Nieboer, MJ Roobol, A Bjartell, EW Steyerberg, D Rizopoulos BJU Int 127, 96-107, 2021 | 6 | 2021 |
Personalized screening intervals for measurement of N-terminal pro-B-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure AS Schuurman, A Tomer, KM Akkerhuis, JJ Brugts, AA Constantinescu, ... European journal of preventive cardiology 28 (9), e11-e14, 2021 | 5 | 2021 |
Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling study AS Schuurman, A Tomer, KM Akkerhuis, EJ Hoorn, JJ Brugts, ... Journal of Nephrology, 1-7, 2021 | 1 | 2021 |
401.5: Development of High-Performing and Multicenter-Validated Dynamic Prediction Models With Longitudinal Measurements of Serum Creatinine and Proteinuria for Death-Censored … S Meziyerh, A Tomer, H Peters-Sengers, D van der Helm, M Coemans, ... Transplantation 106 (9S), S376, 2022 | | 2022 |
Temporal Properties of Vaccine Effectiveness Measures in Presence of Multiple Pathogen Variants and Multiple Vaccines A Tomer, J Biccler arXiv preprint arXiv:2202.06762, 2022 | | 2022 |
Personalized Schedules for Invasive Diagnostic Tests: With Applications in Surveillance of Chronic Non-Communicable Diseases A Tomer | | 2020 |
V14-01 A READY TO USE WEB-APPLICATION PROVIDING A PERSONALIZED BIOPSY SCHEDULE FOR MEN WITH LOW-RISK PCA UNDER ACTIVE SURVEILLANCE A Tomer, D Nieboer, M Roobol, A Bjartell, E Steyerberg, D Rizopoulos Journal of Urology 203, e1306, 2020 | | 2020 |
Personalized screening intervals for measurement of n-terminal pro-b-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure AS Schuurman, A Tomer, KM Akkerhuis, JJ Brugts, AA Constantinescu, ... EUROPEAN HEART JOURNAL 40, 946-946, 2019 | | 2019 |
P1644 Personalized screening intervals for measurement of n-terminal pro-b-type natriuretic peptide improve efficiency of prognostication in patients with chronic heart failure AS Schuurman, A Tomer, KM Akkerhuis, JJ Brugts, AA Constantinescu, ... European Heart Journal 40 (Supplement_1), ehz748. 0403, 2019 | | 2019 |
Web-based Supplementary Materials for “Personalized Schedules for Surveillance of Low Risk Prostate Cancer Patients” A Tomer, D Nieboer, MJ Roobol, EW Steyerberg, D Rizopoulos | | 2000 |
Personalized Schedules for Invasive Diagnostic Tests A Tomer | | |
Supplementary Materials for “Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs” A Tomer, D Rizopoulos, D Nieboer, FJ Drost, MJ Roobol, EW Steyerberg | | |